Article
The Hsd17b13P260S patient variant knock-in male mouse model provides translational insights into HSD17B13 biology.
EBioMedicine - 1 Sept 2026
Slabber Coenraad F, Lenkeit Felina, Grove Kerri, Aebi Alexandra, Orsini Vanessa, Reyes Alejandro, Ludwig Vanessa, Crochemore Christophe, Bergling Sebastian, Wild Sophia, Naumann Ulrike, Enos Karyn, Abrams Austin S, Zeller Hansjoerg, Bhol Raj, Wang Louis, Redmond Emily, Wetzel Kristie, Capodieci Paola, Heikelä Hanna, Martinez-Nieto Guillermo, Mairinoja Laura, Sipilä Petra, Strauss Leena, Baumgarten Birgit U, George Elizabeth L, Heim Markus, Terracciano Luigi, Bouwmeester Antonius, Tchorz Jan S, Poutanen Matti, Ruffner Heinz, Bordoli Mattia R
Abstract excerpt
BACKGROUND: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a prevalent liver disease that can progress to metabolic dysfunction-associated steatohepatitis (MASH), a condition marked by inflammation and fibrosis that increases the risk of cirrhosis, liver failure, and hepatocellular carcinoma. Loss-of-function (LoF) variants of hydroxysteroid 17-β dehydrogenase 13 (HSD17B13), a lipid...
Read the complete abstract on PubMedTopics
- Animals
- Male
- Mice
